1. 169P Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: A 10-year systematic literature review (SLR). (15th December 2019) Authors: Anota, A; Pozet, A; Lefevre, C; Lemasson, H; Cotte, F-E; Guerzider, S; Mouillet, G; Eberst, G; Charton, E; Westeel, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗